205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.47%
Revenue growth at 50-75% of NXPI's 5.70%. Martin Whitman would worry about competitiveness or product relevance.
1.64%
Gross profit growth under 50% of NXPI's 6.27%. Michael Burry would be concerned about a severe competitive disadvantage.
3.82%
EBIT growth below 50% of NXPI's 13.58%. Michael Burry would suspect deeper competitive or cost structure issues.
1.96%
Operating income growth under 50% of NXPI's 13.58%. Michael Burry would be concerned about deeper cost or sales issues.
0.82%
Net income growth under 50% of NXPI's 13.50%. Michael Burry would suspect the firm is falling well behind a key competitor.
0.53%
EPS growth under 50% of NXPI's 13.50%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
1.08%
Diluted EPS growth under 50% of NXPI's 13.62%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.11%
Slight or no buybacks while NXPI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Dividend reduction while NXPI stands at 22.33%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
20.60%
Similar OCF growth to NXPI's 19.62%. Walter Schloss would assume comparable operations or industry factors.
-126.40%
Negative FCF growth while NXPI is at 48.67%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
80.64%
10Y revenue/share CAGR under 50% of NXPI's 167.29%. Michael Burry would suspect a lasting competitive disadvantage.
21.37%
5Y revenue/share CAGR under 50% of NXPI's 91.29%. Michael Burry would suspect a significant competitive gap or product weakness.
41.12%
3Y revenue/share CAGR under 50% of NXPI's 94.71%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
152.14%
10Y OCF/share CAGR under 50% of NXPI's 354.79%. Michael Burry would worry about a persistent underperformance in cash creation.
-17.56%
Negative 5Y OCF/share CAGR while NXPI is at 149.09%. Joel Greenblatt would question the firm’s operational model or cost structure.
-17.95%
Negative 3Y OCF/share CAGR while NXPI stands at 95.83%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
216.94%
Below 50% of NXPI's 505.27%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
31.88%
Below 50% of NXPI's 1616.34%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
25.88%
Below 50% of NXPI's 449.78%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
74.95%
Below 50% of NXPI's 606.08%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
61.29%
Positive 5Y equity/share CAGR while NXPI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
110.37%
Positive short-term equity growth while NXPI is negative. John Neff sees a strong advantage in near-term net worth buildup.
342.27%
Dividend/share CAGR of 342.27% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
99.75%
Dividend/share CAGR of 99.75% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
37.90%
Below 50% of NXPI's 173.17%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
4.21%
Our AR growth while NXPI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
13.41%
Inventory growth well above NXPI's 6.58%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.88%
Asset growth above 1.5x NXPI's 0.27%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.46%
BV/share growth above 1.5x NXPI's 2.94%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
10.79%
Debt growth far above NXPI's 0.03%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
4.84%
R&D growth drastically higher vs. NXPI's 2.08%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-2.74%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.